OGN

OGN screens optically cheap (P/S 0.6, P/E 18.7, P/E on collapsed earnings is misleading) but the fundamentals are deteriorating fast. FY2025 revenue fell 2.9% to $6.22B and net income collapsed 78.4% from $864M to $187M, dragging diluted EPS from a prior trajectory to just $0.72. Net margin compressed to 3.0% and gross profit fell 10.8% even as revenue only slipped 2.9% — a tell that pricing/mix is breaking down, not just volume. The 10-K confirms the cause: roughly $197M of LOE impact in 2025 (Atozet in France/Spain/Japan, Rosuzet in Japan), Singulair price reductions in China/Japan, Dulera losing a US customer contract, and continued China VBP pressure expected for several more quarters.

The capital structure leaves almost no cushion. Long-term debt of $8.63B sits against just $752M of equity (liabilities/equity 16.11x) and $574M of cash (down 15% YoY). Operating cash flow of $700M is still meaningful but fell 25.5%, and management cut dividends paid by 70.4% to $88M — a clear signal that deleveraging now trumps shareholder returns. Filings flag 'substantial levels of indebtedness' as a top risk and disclose unremediated material weaknesses in internal control over financial reporting, which is a governance red flag in a highly levered name.